ALLIANCEBERNSTEIN HOLDING L.P. (AB)
AB Science patent for masitinib in the treatment of metastatic castrate resistant prostate cancer formally granted in the United States with a protection until 2042
AB Science patent for masitinib in the treatment of metastatic castrate resistant prostate cancer formally granted in the United States with a protection until 2042
Volition Advances NETs Program with Sysmex
Rubrik Announces Upcoming Integration with Amazon Bedrock AgentCore to Secure AI Agents
SentinelOne Announces AI Security Integration with Amazon Bedrock AgentCore to Deliver Runtime Guardrails for AI Agents
Digital Realty Launches ServiceFabric® MCP, Bringing AI-Native Programmable Control to 800+ Data Centers
Netskope Announces Upcoming Integration with Amazon Bedrock AgentCore
Salem Media New York Commemorates Americas 250th with Special Broadcast Celebration & Patriotic Performance in Times Square
BidBoardX expands carrier access to committed freight, bringing ease and efficiency to a fragmented marketplace
IRCODE Secures Strategic Investment from Sinclair to Bring Interactive, Measurable Television to Broadcast at Scale
Wijzigingen in de raad van bestuur van Ascencio Management NV